publication date: Jan. 16, 2016

Campaign for Tobacco-Free Kids Demands Recall of Gold Standard Accreditation of the U.S. Chamber of Commerce 


The Campaign for Tobacco-Free Kids said the U.S. Chamber of Commerce is undeserving of its Gold Standard accreditation by the CEO Roundtable on Cancer, saying it should be rescinded because of the trade group’s lobbying efforts against tobacco regulations.

“It is incomprehensible that the U.S. Chamber of Commerce has been recognized by the CEO Roundtable on Cancer for its efforts against cancer when the Chamber has helped the tobacco industry fight life-saving and cancer-preventing tobacco control policies around the world, as recently revealed by a multi-part investigation by The New York Times,” said Matthew Myers, president of the Campaign for Tobacco-Free Kids. “Far from helping to reduce cancer, the Chamber’s pro-tobacco activities are undermining global efforts to fight cancer.”

According to reports from the Times last year, the U.S. Chamber of Commerce has been working internationally against antismoking laws, such as labeling requirements for cigarette packaging and taxes on tobacco products.

CVS Health, which chose to forego selling tobacco products at all its pharmacies and retail stores in 2014, decided to leave the Chamber of Commerce in July 2015, following the Times report.

“CVS Health’s purpose is to help people on their path to better health, and we fundamentally believe tobacco use is in direct conflict with this purpose,” said a CVS spokesperson at the time.

The CEO Roundtable on Cancer is a nonprofit organization that administers the Gold Standard workplace accreditation program, which encourages … Continue reading 42-02 Campaign for Tobacco-Free Kids Demands Recall of Anti-Cancer Accrediation of the U.S. Chamber of Commerce

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.